Government Shutdown Keeps Young Scientists in Limbo

With the lapse in government funding in its fourth week, early-career researchers tell The Scientist how their businesses, jobs, and research have been affected.

| 3 min read
Safety barriers and stop sign in front of United States Capitol

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ABOVE: © ISTOCK.COM, BUMBLEE_DEE

Amber Lucas’s biotech company has been years in the making. The idea for it began when she was a graduate student at Carnegie Mellon University in Pittsburgh, where she worked with her advisor to develop new sample preparation tools for biomarker and drug discovery. She then sought training in entrepreneurship skills and did market research to determine whether there would be interest in the technology. It turned out, there was. So last June, she and her graduate advisor applied for a $225,000 National Science Foundation (NSF) Small Business Innovation grant to seed a startup around the proteome purification technology. In early December, they found out the application had been successful, and began planning the launch of their company.

What they hadn’t planned for was the eventuality that the US government would partially shut down, leaving them with no access to the funds they need to get ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Shawna Williams

    Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor's degree in biochemistry from Colorado College and a graduate certificate and science communication from the University of California, Santa Cruz.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours